Drug recall · November 4, 2026
Atorvastatin Calcium Tablets recall
Why: Presence of Foreign Tablets/Capsules
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Atorvastatin Calcium Tablets, USP, 40mg, 1000 tablets per bottle, Rx only, Manufactured by: MSL Laboratories Private Limited, Telangana - 509228, India; Distributed by: Novadoz Pharmaceuticals LLC, Piscataway, NJ 08854-3714. NDC: 72205-024-99
- Lots / codes
Lot: DRF09618A, Exp 08-31-2029, DRG02110A, Exp 01-31-2030.
- Quantity
- 13,296 1,000-count bottles
- Company
- MSN Laboratories Private Limited (Formulations Division, Unit-II), Rangareddy District
- Distribution
- Nationwide in the USA.
- Initiated
- October 21, 2026 · Voluntary: Firm initiated
- Classified
- October 29, 2026
- Reported
- November 4, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Atorvastatin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.